cms glp 1 coverage MCT2D CMS Issues Coverage Guidance on
Description
[DOI] [PubMed] [Google Scholar] 5.Holst J.J
Tirzepatide is approved as Mounjaro for T2D and as Zepbound for chronic weight management and, notably by the FDA, for treatment of moderate to severe OSA in adults with obesity
Consumers should ask whether their specific HRT prescription, if any, would be FDA-approved, compounded, or pharmacy-dependent before starting treatment
A licensed provider reviews your history and writes the plan
